---
title: "Standard BioTools gets Nasdaq notice for failing $1 minimum bid price rule"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293795610.md"
description: "Standard BioTools received a Nasdaq notice for failing the $1 minimum bid price rule after 30 consecutive days below this threshold. While shares continue trading under LAB with no immediate listing impact, the company must achieve a closing bid of at least $1 for 10 consecutive business days by January 19, 2027, to regain compliance. Options include transferring to the Nasdaq Capital Market for an additional cure period or executing a reverse stock split."
datetime: "2026-07-24T20:39:27.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293795610.md)
  - [en](https://longbridge.com/en/news/293795610.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293795610.md)
---

# Standard BioTools gets Nasdaq notice for failing $1 minimum bid price rule

-   Standard BioTools received a Nasdaq notice for failing the $1 minimum bid price rule after 30 straight business days below $1. \* Shares keep trading on the Nasdaq Global Select Market under LAB; no immediate impact on listing status. \* Deadline to regain compliance is Jan. 19, 2027, requiring a $1+ closing bid for at least 10 consecutive business days. \* Possible extra 180-day cure period if it transfers to the Nasdaq Capital Market; a reverse split remains an option. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Standard BioTools Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-316183), on July 24, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [LAB.US](https://longbridge.com/en/quote/LAB.US.md)

## Related News & Research

- [Standard BioTools Announces Filing of Registration Statement in Connection with Treeline Biosciences Transaction | LAB Stock News](https://longbridge.com/en/news/293208444.md)
- [Faraday Future effects 1-for-150 reverse stock split effective July 24](https://longbridge.com/en/news/293793232.md)
- [SPAR Group shifts to OTCQB as Nasdaq delisting takes effect July 23](https://longbridge.com/en/news/293519669.md)
- [CN Healthy Food Tech Group seeks Nasdaq hearing as trading halt remains in effect](https://longbridge.com/en/news/293381993.md)
- [Citizens Financial (CFG) Q2 2026 Earnings Call Transcript](https://longbridge.com/en/news/293609931.md)